Tags

Type your tag names separated by a space and hit enter

BLIND-SIDED BY COSMETIC VEIN SCLEROTHERAPY: A CASE OF OPHTHALMIC ARTERIAL OCCLUSION.
Retin Cases Brief Rep 2019 Spring; 13(2):185-188RC

Abstract

PURPOSE

Cosmetic vein sclerotherapy is increasingly used to treat varicose veins because of its effectiveness and adherence with British Pharmacopoeia specifications. We present the first documented case of ophthalmic artery occlusion resulting in panocular ischemia secondary to intravascular injection of sodium tetradecyl sulfate sclerosant in a young healthy women seeking treatment for prominent facial veins in her forehead.

METHODS

The patient presented with unilateral sudden loss of vision. Funduscopy demonstrated a pale retina, cherry-red spot, and sclerosant visualized directly at the macula. She underwent emergency treatment for central retinal artery occlusion followed by fundal photographs, fluorescein angiography, and optical coherence tomography.

RESULTS

Despite intervention, the vision remained no perception to light. Magnetic resonance imaging, echocardiography, and Doppler ultrasound were unremarkable. The patient later developed neovascular sequelae requiring laser pan-retinal photocoagulation.

CONCLUSION

Widely regarded as safe, and approved by the U.S. Food and Drug Administration, the only published ocular side effects of foam sclerotherapy are transient visual disturbances or temporary scotomas. This case demonstrates irreversible loss of vision as a previously unreported complication. While undoubtedly rare, we believe physicians and surgeons using sclerosant in the orbital adnexa, face, nose, and sinuses should be aware of this sight-threatening complication of injection and counsel potential patients accordingly.

Authors+Show Affiliations

Department of Ophthalmology, Imperial College Healthcare NHS Trust, London, United Kingdom.No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Case Reports
Journal Article

Language

eng

PubMed ID

28267111

Citation

Arunakirinathan, Meena, et al. "BLIND-SIDED BY COSMETIC VEIN SCLEROTHERAPY: a CASE of OPHTHALMIC ARTERIAL OCCLUSION." Retinal Cases & Brief Reports, vol. 13, no. 2, 2019, pp. 185-188.
Arunakirinathan M, Walker RJE, Hassan N, et al. BLIND-SIDED BY COSMETIC VEIN SCLEROTHERAPY: A CASE OF OPHTHALMIC ARTERIAL OCCLUSION. Retin Cases Brief Rep. 2019;13(2):185-188.
Arunakirinathan, M., Walker, R. J. E., Hassan, N., Ameen, S., & Younis, S. (2019). BLIND-SIDED BY COSMETIC VEIN SCLEROTHERAPY: A CASE OF OPHTHALMIC ARTERIAL OCCLUSION. Retinal Cases & Brief Reports, 13(2), pp. 185-188. doi:10.1097/ICB.0000000000000559.
Arunakirinathan M, et al. BLIND-SIDED BY COSMETIC VEIN SCLEROTHERAPY: a CASE of OPHTHALMIC ARTERIAL OCCLUSION. Retin Cases Brief Rep. 2019;13(2):185-188. PubMed PMID: 28267111.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - BLIND-SIDED BY COSMETIC VEIN SCLEROTHERAPY: A CASE OF OPHTHALMIC ARTERIAL OCCLUSION. AU - Arunakirinathan,Meena, AU - Walker,Robbie J E, AU - Hassan,Noor, AU - Ameen,Sally, AU - Younis,Saad, PY - 2017/3/8/pubmed PY - 2019/5/7/medline PY - 2017/3/8/entrez SP - 185 EP - 188 JF - Retinal cases & brief reports JO - Retin Cases Brief Rep VL - 13 IS - 2 N2 - PURPOSE: Cosmetic vein sclerotherapy is increasingly used to treat varicose veins because of its effectiveness and adherence with British Pharmacopoeia specifications. We present the first documented case of ophthalmic artery occlusion resulting in panocular ischemia secondary to intravascular injection of sodium tetradecyl sulfate sclerosant in a young healthy women seeking treatment for prominent facial veins in her forehead. METHODS: The patient presented with unilateral sudden loss of vision. Funduscopy demonstrated a pale retina, cherry-red spot, and sclerosant visualized directly at the macula. She underwent emergency treatment for central retinal artery occlusion followed by fundal photographs, fluorescein angiography, and optical coherence tomography. RESULTS: Despite intervention, the vision remained no perception to light. Magnetic resonance imaging, echocardiography, and Doppler ultrasound were unremarkable. The patient later developed neovascular sequelae requiring laser pan-retinal photocoagulation. CONCLUSION: Widely regarded as safe, and approved by the U.S. Food and Drug Administration, the only published ocular side effects of foam sclerotherapy are transient visual disturbances or temporary scotomas. This case demonstrates irreversible loss of vision as a previously unreported complication. While undoubtedly rare, we believe physicians and surgeons using sclerosant in the orbital adnexa, face, nose, and sinuses should be aware of this sight-threatening complication of injection and counsel potential patients accordingly. SN - 1937-1578 UR - https://www.unboundmedicine.com/medline/citation/28267111/BLIND_SIDED_BY_COSMETIC_VEIN_SCLEROTHERAPY:_A_CASE_OF_OPHTHALMIC_ARTERIAL_OCCLUSION_ L2 - http://Insights.ovid.com/pubmed?pmid=28267111 DB - PRIME DP - Unbound Medicine ER -